Status:

UNKNOWN

Blood Glucose Differences Between Left Arm and Right Arm Using a Continuous Glucose Monitor

Lead Sponsor:

University of the Pacific

Conditions:

Diabetes

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Interest in continuous glucose monitors (CGMs) is growing for use in evaluating real time glucose levels and in detecting extreme high and low values. A CGM is a small device primarily placed on the p...

Detailed Description

Continuous glucose monitoring (CGM) is an emerging field for diabetes management. CGM allows providers to individualize therapy by looking at real time glucose levels, detect changes in blood glucose ...

Eligibility Criteria

Inclusion

  • Adults 18-65 years of age
  • Willing to wear CGM device for 12-14 days on both arms
  • Have active health insurance
  • Willing to refrain from any heat therapy for the duration of the study
  • Having an interest to comply with the fasting requirements of the study as appropriate
  • Willingness to maintain once daily email responses

Exclusion

  • Any active dermatologic condition on the upper arms
  • Implanted medical devices (i.e. pacemaker)
  • Critically ill or dialysis patients
  • Planned magnetic resonance imaging screening, computed tomography scan, x-ray imaging or high-frequency electrical heat treatment during study period
  • Current systemic infections
  • Subjects who are unable to fully understand the study or consent process will not be included in the study due to the lack of a qualified medical translator
  • Refusal to sign the informed consent document
  • Pregnant, planned-pregnancy in the next 30 days, or breast-feeding
  • Active eating disorder
  • Taking any medications that have an increased risk of hypoglycemia (e.g. sulfonylureas, insulin, thiazolidinediones) as determined by the primary investigators
  • Taking medications for obesity
  • You have one of the following medical conditions that can cause rapid weight loss: rheumatoid arthritis, hyperthyroidism, irritable bowel syndrome, cancer, HIV, active tuberculosis, Addison's disease
  • In an active weight loss program
  • On a specialized diet (e.g. Weight Watchers, ketogenic diet, Atkins diet)
  • Completed a specialized diet in the past 2 weeks (e.g. Weight Watchers, ketogenic diet, Atkins diet)
  • History of adverse events (i.e. shaking, dizziness, fatigue, fainting) during any prior fasting experience
  • Below the age of 18 years and above the age of 65 years

Key Trial Info

Start Date :

September 20 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2019

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT04102657

Start Date

September 20 2019

End Date

November 1 2019

Last Update

September 25 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of the Pacific

Stockton, California, United States, 95211